Alvotech Files 6-K Report
Ticker: ALVOW · Form: 6-K · Filed: Jun 5, 2025 · CIK: 1898416
| Field | Detail |
|---|---|
| Company | Alvotech (ALVOW) |
| Form Type | 6-K |
| Filed Date | Jun 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
Alvotech filed a 6-K on 6/5/25, confirming it's a foreign private issuer filing 20-F.
AI Summary
Alvotech, a biopharmaceutical company, filed a Form 6-K on June 5, 2025. The filing is a report of a foreign private issuer and indicates that Alvotech files annual reports under Form 20-F. The company's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg.
Why It Matters
This filing provides routine updates for investors regarding Alvotech's status as a foreign private issuer and its reporting obligations.
Risk Assessment
Risk Level: low — This is a routine administrative filing with no new financial or operational information that would typically impact risk.
Key Players & Entities
- Alvotech (company) — Registrant
- 001-41421 (company) — SEC File Number
- 20-F (company) — Annual Report Form
- 6-K (company) — Filing Type
- June 5, 2025 (date) — Filing Date
FAQ
What type of filing is this Form 6-K?
This Form 6-K is a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934.
What is Alvotech's SEC File Number?
Alvotech's SEC File Number is 001-41421.
Does Alvotech file annual reports under Form 20-F or 40-F?
Alvotech indicates it files annual reports under cover of Form 20-F.
Where is Alvotech's principal executive office located?
Alvotech's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg.
What is the filing date of this Form 6-K?
This Form 6-K was filed on June 5, 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 5, 2025 regarding Alvotech (ALVOW).